Allogenic human umbilical cord derived mesenchymal stem cell (Anming Kangyuan Pharma)

人脐带间充质干细胞（安明康源制药）

Report date: 2026/03/27 14:51:53

Base Information

Drug NameAllogenic human umbilical cord derived mesenchymal stem cell (Anming Kangyuan Pharma)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesAnming Kangyuan Pharmaceutical (Jilin) Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAnming Kangyuan Pharmaceutical (Jilin) Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A